找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Endocrine Therapy of Breast Cancer III; Franco Cavalli Conference proceedings 1989 Springer-Verlag Berlin Heidelberg 1989 breast cancer.ca

[復制鏈接]
查看: 26671|回復: 38
樓主
發(fā)表于 2025-3-21 17:07:36 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Endocrine Therapy of Breast Cancer III
編輯Franco Cavalli
視頻videohttp://file.papertrans.cn/310/309737/309737.mp4
叢書名稱ESO Monographs
圖書封面Titlebook: Endocrine Therapy of Breast Cancer III;  Franco Cavalli Conference proceedings 1989 Springer-Verlag Berlin Heidelberg 1989 breast cancer.ca
描述The European School of Oncology came into existence to respond to a need for information, education and training in the field of the diagnosis and treatment of cancer. There are two main reasons why such an initiative was considered necessary. Firstly, the teaching of oncology requires a rigorously multidiscipli- nary approach which is difficult for the Universities to put into practice since their system is mainly disciplinary orientated. Secondly, the rate of technological development that impinges on the diagnosis and treatment of cancer has been so rapid that it is not an easy task for medical faculties to adapt their curricula flexibly. With its residential courses for organ pathologies and the seminars on new techniques (laser, monoclonal antibodies, imaging techniques etc.) or on the principal therapeutic controversies (conservative or mutilating surgery, primary or adjuvant chemotherapy, radiotherapy alone or integrated), it is the ambition of the European School of Oncology to fill a cultural and scientific gap and, thereby, create a bridge between the University and Industry and between these two and daily medical practice. One of the more recent initiatives of ESO has be
出版日期Conference proceedings 1989
關鍵詞breast cancer; cancer; clinical trial; oncology; quality of life; Radiaton Oncology
版次1
doihttps://doi.org/10.1007/978-3-642-74504-1
isbn_softcover978-3-642-74506-5
isbn_ebook978-3-642-74504-1
copyrightSpringer-Verlag Berlin Heidelberg 1989
The information of publication is updating

書目名稱Endocrine Therapy of Breast Cancer III影響因子(影響力)




書目名稱Endocrine Therapy of Breast Cancer III影響因子(影響力)學科排名




書目名稱Endocrine Therapy of Breast Cancer III網(wǎng)絡公開度




書目名稱Endocrine Therapy of Breast Cancer III網(wǎng)絡公開度學科排名




書目名稱Endocrine Therapy of Breast Cancer III被引頻次




書目名稱Endocrine Therapy of Breast Cancer III被引頻次學科排名




書目名稱Endocrine Therapy of Breast Cancer III年度引用




書目名稱Endocrine Therapy of Breast Cancer III年度引用學科排名




書目名稱Endocrine Therapy of Breast Cancer III讀者反饋




書目名稱Endocrine Therapy of Breast Cancer III讀者反饋學科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權限
沙發(fā)
發(fā)表于 2025-3-21 21:25:32 | 只看該作者
Progression from Steroid Responsive to Unresponsive State in Breast Cancer,ifferences or even the derivation of these two classes of breast cancer. The pioneering work of Foulds [1] produced the concept of progression from responsive to unresponsive state in which he stressed that multiple pathways of progression occurred. Unresponsive tumours could be formed from responsi
板凳
發(fā)表于 2025-3-22 01:17:24 | 只看該作者
地板
發(fā)表于 2025-3-22 06:51:23 | 只看該作者
Adjuvant Systemic Therapy for Breast Cancer Patients Without Lymph Node Metastases (N-),cancer and axillary clearance. Patients with N- disease who were treated in the more recent controlled clinical trials have higher relapse rates than those entered in the earlier series from which our perception of prognosis for these patients has been derived. This could be due to a reporting bias,
5#
發(fā)表于 2025-3-22 10:41:46 | 只看該作者
New Developments in the Field of Aromatase Inhibitors, oestrogens may induce regression of tumour growth. In premenopausal women the ovaries are the main source of oestrogens, while in postmenopausal women oestrogens are mainly derived from extra-ovarian aromatisation of androgenic precursors such as androstenedione [1].
6#
發(fā)表于 2025-3-22 14:31:17 | 只看該作者
Resistance to Antioestrogen Therapy: a Challenge for the Future,hough another 20% have stable disease. If oestrogen receptor-positive patients are selected for study, tamoxifen produces a 50–60% objective response rate. Nevertheless, about 13% of oestrogen receptor-negative patients can have a response to therapy.
7#
發(fā)表于 2025-3-22 20:39:18 | 只看該作者
8#
發(fā)表于 2025-3-23 01:01:07 | 只看該作者
9#
發(fā)表于 2025-3-23 02:25:54 | 只看該作者
10#
發(fā)表于 2025-3-23 08:23:12 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-28 01:22
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
达日县| 凉城县| 山西省| 安新县| 广元市| 九龙县| 大厂| 仁怀市| 邯郸市| 曲沃县| 阜阳市| 萨迦县| 陵川县| 克东县| 慈溪市| 青阳县| 姜堰市| 讷河市| 香格里拉县| 宁远县| 舞钢市| 新巴尔虎右旗| 建德市| 天等县| 和林格尔县| 霞浦县| 台北县| 耒阳市| 应用必备| 武定县| 闸北区| 那坡县| 新闻| 乃东县| 科技| 青龙| 西和县| 太仓市| 丰镇市| 高阳县| 库尔勒市|